iRhythm Technologies (IRTC)
(Delayed Data from NSDQ)
$70.67 USD
+0.74 (1.06%)
Updated Aug 21, 2024 04:00 PM ET
After-Market: $70.55 -0.12 (-0.17%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IRTC 70.67 +0.74(1.06%)
Will IRTC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRTC
All You Need to Know About iRhythm Technologies (IRTC) Rating Upgrade to Buy
IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
IRTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for IRTC
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and Irhythm Technologies (IRTC)
Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Oncolytics Biotech (ONCY) and Irhythm Technologies (IRTC)
Irhythm Technologies (IRTC) Receives a Buy from Wells Fargo
iRhythm Technologies Inc (IRTC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ...